Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Endocrinological Investigation|August 20, 2025
Clinical and genetic features of older patients with pheochromocytomas and paragangliomas: A multicenter retrospective studyXiaowen Xu, Yingjie Shen, Jingjing Jiang, et al.
Cellular and Molecular Life Sciences : CMLS|July 8, 2024
Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancerGaowei Huang, Jinwen Liu, Anze Yu, et al.
Theranostics|February 4, 2021
Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancerJiao Hu, Anze Yu, Belaydi Othmane, et al.
Frontiers in Immunology|September 16, 2021
N<sup>6</sup>-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic TargetChao Quan, Othmane Belaydi, Jiao Hu, et al.
Cell Death and Differentiation|December 13, 2024
Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axisAnze Yu, Liangmin Fu, Lanyu Jing, et al.
Journal for Immunotherapy of Cancer|October 6, 2023
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8<sup>+</sup> T cell infiltration and functional transitionAnze Yu, Jiao Hu, Liangmin Fu, et al.
Cell Reports|July 15, 2026
YAP1 lactylation confers cisplatin resistance and prognostic value by suppressing ferroptosis via FOSL1 in bladder cancerZheyu Ai, Hao Zhou, Lijuan Jiang, et al.
Cell Proliferation|May 16, 2025
Deciphering the Immunomodulatory Function of GSN<sup>+</sup> Inflammatory Cancer-Associated Fibroblasts in Renal Cell Carcinoma Immunotherapy: Insights From Pan-Cancer Single-Cell Landscape and Spatial Transcriptomics AnalysisShan Li, Xinwei Zhou, Haoqian Feng, et al.
Cancer Letters|March 10, 2024
LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and redirecting M2-like macrophage polarisation in bladder cancerHansen Lin, Liangmin Fu, Xinwei Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 15, 2025
TWF2 Drives Tumor Progression and Sunitinib Resistance in Renal Cell Carcinoma through Hippo Signaling SuppressionLiangmin Fu, Wuyuan Liao, Youyan Tan, et al.
Pageof 4